Literature DB >> 29229120

Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection.

Robert D Kirkton1, Heather L Prichard1, Maribel Santiago-Maysonet1, Laura E Niklason2, Jeffrey H Lawson3, Shannon L M Dahl4.   

Abstract

BACKGROUND: Synthetic expanded polytetrafluorethylene (ePTFE) grafts are routinely used for vascular repair and reconstruction but prone to sustained bacterial infections. Investigational bioengineered human acellular vessels (HAVs) have shown clinical success and may confer lower susceptibility to infection. Here we directly compared the susceptibility of ePTFE grafts and HAV to bacterial contamination in a preclinical model of infection.
MATERIALS AND METHODS: Sections (1 cm2) of ePTFE (n = 42) or HAV (n = 42) were inserted within bilateral subcutaneous pockets on the dorsum of rats and inoculated with Staphylococcus aureus (107 CFU/0.25 mL) or Escherichia coli (108 CFU/0.25 mL) before wound closure. Two weeks later, the implant sites were scored for abscess formation and explanted materials were halved for quantification of microbial recovery and histological analyses.
RESULTS: The ePTFE implants had significantly higher abscess formation scores for both S. aureus and E. coli inoculations compared to that of HAV. In addition, significantly more bacteria were recovered from explanted ePTFE compared to HAV. Gram staining of explanted tissue sections revealed interstitial bacterial contamination within ePTFE, whereas no bacteria were identified in HAV tissue sections. Numerous CD45+ leukocytes, predominantly neutrophils, were found surrounding the ePTFE implants but minimal intact neutrophils were observed within the ePTFE matrix. The host cells surrounding and infiltrating the HAV explants were primarily nonleukocytes (CD45-).
CONCLUSIONS: In an established animal model of infection, HAV was significantly less susceptible to bacterial colonization and abscess formation than ePTFE. The preclinical findings presented in this manuscript, combined with previously published clinical observations, suggest that bioengineered HAV may exhibit low rates of infection.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial infection; Expanded polytetrafluorethylene; Hemodialysis; Neutrophils; Synthetic vascular grafts; Tissue-engineered blood vessels

Mesh:

Substances:

Year:  2017        PMID: 29229120     DOI: 10.1016/j.jss.2017.08.035

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  Challenges and novel therapies for vascular access in haemodialysis.

Authors:  Jeffrey H Lawson; Laura E Niklason; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

Review 2.  Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective.

Authors:  Andras P Durko; Magdi H Yacoub; Jolanda Kluin
Journal:  Front Cardiovasc Med       Date:  2020-04-15

Review 3.  Arteriovenous access in hemodialysis: A multidisciplinary perspective for future solutions.

Authors:  Bernd Stegmayr; Christian Willems; Thomas Groth; Albino Martins; Nuno M Neves; Khosrow Mottaghy; Andrea Remuzzi; Beat Walpoth
Journal:  Int J Artif Organs       Date:  2020-05-22       Impact factor: 1.595

4.  Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access.

Authors:  Tomasz Jakimowicz; Stanislaw Przywara; Jakub Turek; Alison Pilgrim; Michal Macech; Norbert Zapotoczny; Tomasz Zubilewicz; Jeffrey H Lawson; Laura E Niklason
Journal:  EJVES Vasc Forum       Date:  2022-01-10

5.  Surgical management of an infected external iliac artery interposition graft with a bioengineered human acellular vessel.

Authors:  Christy Guth; Thomas Naslund
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-10-14

Review 6.  Failure Analysis of TEVG's I: Overcoming the Initial Stages of Blood Material Interaction and Stabilization of the Immune Response.

Authors:  Maria A Rodriguez-Soto; Natalia Suarez Vargas; Alejandra Riveros; Carolina Muñoz Camargo; Juan C Cruz; Nestor Sandoval; Juan C Briceño
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

7.  Mechanically reinforced biotubes for arterial replacement and arteriovenous grafting inspired by architectural engineering.

Authors:  Dengke Zhi; Quhan Cheng; Adam C Midgley; Qiuying Zhang; Tingting Wei; Yi Li; Ting Wang; Tengzhi Ma; Muhammad Rafique; Shuang Xia; Yuejuan Cao; Yangchun Li; Jing Li; Yongzhe Che; Meifeng Zhu; Kai Wang; Deling Kong
Journal:  Sci Adv       Date:  2022-03-16       Impact factor: 14.136

8.  Programming of Regulatory T Cells In Situ for Nerve Regeneration and Long-Term Patency of Vascular Grafts.

Authors:  Yanhong Wang; Fangchao Xue; Yanzhao Li; Lin Lin; Yeqin Wang; Shanlan Zhao; Xingli Zhao; Yong Liu; Ju Tan; Gang Li; Haoran Xiao; Juan Yan; Hao Tian; Min Liu; Qiao Zhang; Zhaojing Ba; Lang He; Wenyan Zhao; Chuhong Zhu; Wen Zeng
Journal:  Research (Wash D C)       Date:  2022-07-19

9.  Vascular Remodeling of Clinically Used Patches and Decellularized Pericardial Matrices Recellularized with Autologous or Allogeneic Cells in a Porcine Carotid Artery Model.

Authors:  Jaroslav Chlupac; Roman Matejka; Miroslav Konarik; Robert Novotny; Zuzana Simunkova; Iveta Mrazova; Ondrej Fabian; Milan Zapletal; Zdenek Pulda; Jan Falk Lipensky; Jana Stepanovska; Karel Hanzalek; Antonin Broz; Tomas Novak; Alena Lodererova; Ludek Voska; Theodor Adla; Jiri Fronek; Miroslav Rozkot; Serhiy Forostyak; Peter Kneppo; Lucie Bacakova; Jan Pirk
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.